Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program

Publisher: John Wiley & Sons Inc

E-ISSN: 1549-490x|23|2|193-202

ISSN: 1083-7159

Source: The Oncologist, Vol.23, Iss.2, 2018-02, pp. : 193-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content